Isomorphic Labs
Builds an AI-first drug design engine to accelerate discovery and development across multiple therapeutic areas
$2.1BSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Builds an AI-first drug design engine to accelerate discovery and development across multiple therapeutic areas